Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Lymphoid 3Gastrointestinal 3Thoracic 2Head & Neck 2Dermatologic 2Other hematologic neoplasm 1Myeloid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Leukemia, Myeloid, Acute 514Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Myelodysplastic Syndromes 234Lymphoma, Non-Hodgkin 173Lymphoma 162Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Hematologic Neoplasms 133Multiple Myeloma 121Lymphoma, Follicular 120Lymphoma, Large B-Cell, Diffuse 119Lymphoma, Mantle-Cell 118Recurrence 115Hodgkin Disease 99Burkitt Lymphoma 99Lymphoma, B-Cell, Marginal Zone 98Congenital Abnormalities 78Leukemia, Myelomonocytic, Chronic 77Leukemia, Myeloid, Chronic-Phase 68Neoplasms 67Myeloproliferative Disorders 66Lymphoma, Large-Cell, Immunoblastic 64Blast Crisis 59Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Waldenstrom Macroglobulinemia 53Primary Myelofibrosis 53Lymphoma, T-Cell, Cutaneous 52Leukemia, Myeloid, Accelerated Phase 50Neoplasms, Plasma Cell 48

Interventions

obinutuzumab 1duvelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hereditary Sensory and Autonomic Neuropathies × Other hematologic neoplasm × Clear all
NCT02292225 2023-02-27

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

SecuraBio

Phase 1 Terminated
3 enrolled
LymphoidOther hematologic neoplasm

Hereditary Sensory and Autonomic Neuropathies, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡